NEETABEN SAXENA: Open Payments
NPI 1700894011 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 11 payments from 6 companies in 2025. Trend: 2023 $86 · 2024 $223 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $65 |
| Novo Nordisk Inc | 3 | $64 |
| Ardelyx, Inc. | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Calliditas Therapeutics US Inc. | 1 | $18 |
Products named: Veltassa, JARDIANCE, Wegovy, IBSRELA, ULTOMIRIS, TARPEYO.
Industry payments across NC — which companies pay providers there.
